Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: 2017-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,708,738
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-034284
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
May 22, 2017
Reporting period
May 11, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub